for the samples are known to high accuracy.Lead author Dr Gonzalo Vallejo-Fernandez, from York's Department of Physics, said: While clinical trials have shown the potential of magnetic nanoparticles for cancer
Further, in prostate cancer, lipid coated PLGA nanoparticle was used with luciferase siRNA showed in vitro knock down of genes [76]. Another formulation was developed of PLGA-PEI nanoparticles using double emulsion-solvent evaporation technique, using luciferase as the oligonucleotide for silencing. ...
Antigen-specific immunotherapies (ASITs) for T1D range from peptides, proteins, gene transfer, nanoparticles, cell therapies, or biomimicry of naturally occurring tolerogenic processes. These strategies offer several advantages, particularly their potential to target the underlying autoimmune responses without...
Improving tumor treatment through intratumoral injection of drug-loaded magnetic nanoparticles and low-intensity ultrasound Article Open access 16 January 2024 Introduction Glioblastoma multiforme (GBM) is a highly aggressive and deeply penetrating brain cancer that is notoriously difficult to treat1,2,3,...
most cancer treatments kill not only the dangerous cells but the healthy ones as well.Nanoparticles will allow doctors to attack cancerous tumors without disturbing healthy cells.Thus,it can deliver cancer-killing drugs to the cancer cells and allow doctors to deliver cancer t...
• Targeted Cancer Therapy • Custom Made Medicine - Pharmacogenomics • Nanotechnology and its Application in Medicine - What are Nanoparticles? • Red Biotechnology and Cure of Tuberculosis • Patho-Biotechnology: Solution to Fight Antibiotic Resistance Bacteria? • A Baby Please With a...
[54]. Celgene has a portfolio of albumin-based nanoparticles for cancer treatment, which have been presented in a report by Desai [94]. In this report, preclinical studies of ABI-008 and ABI-009 are described. ABI-008 contains the active drug docetaxel. It has completed phase I/II [95]...
Kit Yu Lu, MD, discusses the applications of T-DXd and sacituzumab govitecan for patients with breast cancer. A Sneak Peek at 2025 ASCO From the GU Perspective Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD May 16th 2025 Podcast Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD...
Li et al., “Fabrication of pH-Responsive Nanocomposites of Gold Nanoparticles/Poly(4-vinylpyridine)”, Chem. Mater., 19, 2007, pp. 412-417. Liu et al., “pH-Sensitive Photoluminescence of CdSe/ZnSe/ZnS Quantum Dots in Human Ovarian Cancer Cells”, J. Phys. Chem., 111, 2007, pp. ...
According to yet another embodiment, the pharmaceutical composition comprising as an active ingredient the antibody of the invention is preferably used for the treatment of cancer. According to yet another embodiment, the pharmaceutical composition may be administered either following detection of primary ...